Pentwater Capital Management LP Pure Tech Health PLC Transaction History
Pentwater Capital Management LP
- $15 Billion
- Q2 2025
A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 50,000 shares of PRTC stock, worth $875,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000
Previous 33,560
48.99%
Holding current value
$875,000
Previous $663,000
30.02%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding PRTC
# of Institutions
9Shares Held
353KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC243KShares$4.25 Million0.19% of portfolio
-
Portolan Capital Management, LLC Boston, MA27.8KShares$486,4120.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny23.9KShares$417,4970.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$128,1700.04% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$29,4870.02% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $488M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...